InvestorsHub Logo
Followers 46
Posts 4240
Boards Moderated 0
Alias Born 08/21/2003

Re: Really People post# 103728

Saturday, 01/01/2022 7:23:33 PM

Saturday, January 01, 2022 7:23:33 PM

Post# of 113729
We have more competition a recent SPAC PRDS offered at 10 and doing well.

The company’s lead program, PBI-0451, an oral antiviral drug candidate, is designed to inhibit an essential viral protein, the main protease (Mpro) of SARS-CoV-2, the virus causing COVID-19. The main protease is highly similar across all coronaviruses – including SARS, MERS and the SARS-CoV-2 emerging coronavirus variants.

Already in Phase 1 and almost complete. Company started in June 2020 so they know how to move fast....I hope SBFM is aware of them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News